Latest news

2 years 9 months ago
From today, new direct-acting antiviral medicines to treat chronic Hepatitis C should start to be made available to eligible patients in England within the NHS, a much broader group of people lving with hepatitis C than were initialy provided with treatment under the Early Access Scheme. These treatments are fast acting, relatively side-effect free and have been shown to free the majority of patients of the virus.
2 years 10 months ago
An Early Day Motion tabled by Jim Shannon MP and calls on the Government, NHS England and Public Health England to work towards eliminating hepatitis C as a major public health concern by publishing a national improvement framework as a matter of urgency. The planned national improvement framework for hepatitis C, first announced in July 2014 with the aim of driving improvements in awareness, testing and combined work to address hepatitis C, is still awaiting publication, having been delayed by NHS England.
2 years 11 months ago
Make sure your opinion is included in decision making processes. Help ensure patients get the hepatitis C treatment they are entitled to. And have your voice heard!
3 years 1 day ago
The Financial Review Group, which was established by the Scottish Government following the publication of the Penrose Inquiry earlier this year, has today submitted to the Scottish Government its recommendations for the reform of the current financial support arrangements for people affected by infected NHS blood and blood products.
3 years 3 days ago
The NHS has to respond to the financial and demographic challenges that threaten its long-term sustainability. The Hepatitis C Trust is part of an expert group looking at how to tackle the increasingly urgent challenge of making our health and care services sustainable for the future. In June 2014, the culmination of this work after a year of research and consultation saw AbbVie, in partnership with the College of Medicine, launched a report on sustainable healthcare: Patient, manager, expert, individual. It made recommendations for change around three important priorities:
3 years 2 weeks ago
 With the new treatments approved for use on the NHS last week in final guidance released by the National Institute for Health and Care Excellence (NICE), a huge opportunity now exists to eliminate hepatitis C as a serious public health concern – if action is taken.
3 years 3 weeks ago
Following the release last month of provisional recommendations for access to several new treatments for hepatitis C (see The Hepatitis C Trust news story here), the National Institute for Health and Care Excellence (NICE) has today published final guidance recommending Harvoni*, Viekirax (with our without Exviera)** and Daklinza*** for treatment of people with certain genotypes of hepatitis C.
3 years 3 weeks ago
Kirsty Williams, Welsh Assembly Member for Brecon and Radnorshire and leader of the Welsh Liberal Democrats, visited University Hospital of Wales in Cardiff on 18th November to find out about the treatment services on offer to people in Cardiff and the surrounding areas with hepatitis C, as well as to find out more about the new Welsh Liver Disease Delivery Plan.
3 years 3 weeks ago
This year sees the first European HIV-Hepatitis Testing Week, taking place between 20th - 27th November, with the inclusion of hepatitis an acknowledgment of how important tackling hepatitis C, a leading cause of liver disease, is to public health. Effective testing and screening are central not just to our ability to provide treatment for those living with hepatitis C but also to limit the number of infections. Recent medical advances mean hepatitis C can now be treated quickly, effectively and with limited side effects.
3 years 1 month ago
A report by the Advisory Council on the Misuse of Drugs (ACMD) addresses the treatment of hepatitis C amongst people who use heroin. It highlights how hepatitis C could be eliminated amongst people in drug treatment and how the variations in access to treatment for hepatitis C reduces the likelihood of successful outcomes from drug treatment.